Contineum Therapeutics, Inc.
CTNM • NASDAQ • Stock Fundamentals
Contineum Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carmine N. Stengone, with a market cap of $443.4M.
Market Cap$443.4M
CEOCarmine N. Stengone
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Contineum Therapeutics, Inc. FAQ
Common questions about Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. (CTNM) has a market capitalization of $443.4M and trades on NASDAQ.